Bone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationBone MarrowGraft vs Host DiseaseHematopoietic Stem CellsBone Marrow CellsTransplantation, AutologousTransplantation ConditioningLiver TransplantationTransplantation ChimeraWhole-Body IrradiationGraft SurvivalTissue DonorsStem Cell TransplantationLeukemiaTransplantation, IsogeneicKidney TransplantationHematologic NeoplasmsBusulfanHistocompatibility TestingBone and BonesAnemia, AplasticHistocompatibilityRecurrenceTreatment OutcomeHematopoiesisGraft RejectionTransplantation ImmunologyImmunosuppressive AgentsMice, Inbred C57BLGraft vs Tumor EffectLeukemia, Myeloid, AcuteRemission InductionHeart TransplantationCyclophosphamideHematopoietic Stem Cell MobilizationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingStem CellsTime FactorsCombined Modality TherapyAntigens, CD34Precursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationPeripheral Blood Stem Cell TransplantationLymphocyte DepletionAcute DiseaseImmunosuppressionRetrospective StudiesSurvival AnalysisGraft vs Leukemia EffectHepatic Veno-Occlusive DiseaseRadiation ChimeraLeukemia, MyeloidT-LymphocytesGranulocyte Colony-Stimulating FactorMyelodysplastic SyndromesCord Blood Stem Cell TransplantationBone Marrow DiseasesMultiple MyelomaHLA AntigensOrgan TransplantationCyclosporineSurvival RateColony-Forming Units AssayLymphocyte TransfusionLymphoma, Non-HodgkinNuclear FamilyCell DifferentiationGraft vs Host ReactionMyeloablative AgonistsMelphalanDisease-Free SurvivalCell TransplantationAntineoplastic Combined Chemotherapy ProtocolsBone Marrow ExaminationLeukocyte TransfusionFollow-Up StudiesCytomegalovirus InfectionsSevere Combined ImmunodeficiencyFlow CytometryIslets of Langerhans TransplantationChimeraHematologic DiseasesVidarabineTransplantationMice, Inbred BALB CPancreas TransplantationBlood CellsCell SeparationBone RemodelingCells, CulturedBone Marrow NeoplasmsLymphomaSalvage TherapyFetal BloodCell LineageSpleenTransplantation Tolerance